Ria Vos

More than 30 years have passed since I started working in preclinical drug development. Initially, in operational and project management positions within a pharmaceutical company in the Netherlands. After 12 years in preclinical DMPK and toxicology, I continued my career as a consultant using the name Admeritox. Over the years, I have contributed to more than 125 projects, covering several therapeutic areas and involving small chemical pharmaceuticals, biologics, medical devices and advanced therapy medicinal products. Contributions have ranged from the preparation/analysis of preclinical development strategies and implementation of associated studies to safety evaluations and the writing of preclinical parts of regulatory documents. As a consultant, I have worked with Starodub for several years and much appreciate the team spirit and the focus on quality of output. I am pleased to contribute to the team as a preclinical expert and coach.